2JD-25530-98150
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 338 / FL
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2020-12-29
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Diarrhea, Abdominal painAdult check-in
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-04
- 2021-01-11
- 2021-01-20
-
2021-01-25
Dose 2 — Moderna
-
2021-01-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-03
- 2021-02-17
- 2021-02-22
- 2021-03-03
- 2021-03-08
- 2021-04-26
- 2021-07-28
-
2021-12-20
Dose 3 — Moderna
-
2021-12-23
Survey response — days 1–6 daily, dose 3MedDRA: Eyelid ptosis — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: Eyelid droopingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
- 2021-12-26
- 2021-12-29
- 2022-03-21
- 2022-06-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-12-20 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-29 | priority 2/3 |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Eyelid drooping
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Eyelid ptosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release